Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01154296 · ClinicalTrials.gov registry record · NA
HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 5,012
- Enrollment target
NCT01154296 is a NA study that has completed, run by Columbia University. The registered enrollment target is 5,012 participants.
The verdict
NCT01154296, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,012 participants
- Enrollment target
Study Summary
Project Aware is a randomized controlled clinical trial in which individuals seeking medical or health services at sexually transmitted disease (STD) clinics are recruited to participate in a multi-center HIV testing and counseling study. The investigators will assess the relative effectiveness and cost-effectiveness of (1) on-site HIV rapid testing with brief, participant-tailored prevention counseling vs. (2) on-site HIV rapid testing with information only. The investigators will evaluate the effect of counseling on one primary outcome: STI incidence. Secondary outcomes will be reduction of sexual risk behaviors, substance use during sex (i.e., being under the influence during sex) and cost and cost effectiveness of counseling and testing. Participants will be assessed for sexually transmitted infections, HIV testing history and sexual and drug use risk behaviors at baseline and at 6-months follow-up. Approximately 5,000 individuals seeking medical or health services from approximately 9 STD clinics throughout the United States will be randomized. These individuals will be 18 years of age or older and efforts will be made to recruit a sample of study participants that reflects the proportion of minorities and gender in the STD clinic performance sites from which the investigators are recruiting.
Interventions
- BEHAVIORAL RESPECT-2 Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,012 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01154296
The ClinicalTrials.gov registry entry for NCT01154296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,012 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RESPECT-2 Counseling is the first listed.
NCT01154296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01154296 about?
NCT01154296 is a clinical study titled "HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.". Project Aware is a randomized controlled clinical trial in which individuals seeking medical or health services at sexually transmitted disease (STD) clinics are recruited to participate in a multi-center HIV testing and counseling study. The investigators will assess the relative effectiveness and ...
What is the current status of trial NCT01154296?
This trial is currently completed. It is a NA study. The enrollment target is 5,012 participants. The study started on 2010-04. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01154296?
The interventions under investigation include: RESPECT-2 Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01154296?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.